Inflammatory Complications of Intravitreal Anti-VEGF Injections

Intravitreal injection of anti-vascular endothelial growth factor (anti-VEGF) agents is a commonly used therapy for numerous retinal diseases. The most commonly used of these medications are bevacizumab, ranibizumab, aflibercept, and brolucizumab. However, intravitreal administration of these agents...

Descripción completa

Detalles Bibliográficos
Autores principales: Cox, Jacob T., Eliott, Dean, Sobrin, Lucia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7957879/
https://www.ncbi.nlm.nih.gov/pubmed/33801185
http://dx.doi.org/10.3390/jcm10050981

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7957879/
https://www.ncbi.nlm.nih.gov/pubmed/33801185
http://dx.doi.org/10.3390/jcm10050981

Ejemplares similares